Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pulmonary levodopa dry powder pharmacokinetic study in Parkinson's disease
NL-OMON42667Phase 2Active, not recruiting
- Sponsor
- Martini Ziekenhuis
- Start
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of levodopa in Parkinson's disease (PD) (2 arms), sponsored by Martini Ziekenhuis. Primary endpoints: Maximum plasma concentration of levodopa, Time to maximum plasma concentration of levodopa and 1 more. Started Oct 2016; status: active, not recruiting.
02
Drugs
levodopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NL-OMON42667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON42667.